Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  valganciclovir
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-8 of 8 for your search:
Start Over
Antiviral Treatment of Chronic Lymphocytic Leukemia
Phase: Phase IV
Type: Treatment
Status: Enrolling by invitation
Age: 18 and over
Sponsor: Other
Protocol IDs: EudraCT_2010-021786-78, NCT01255644
Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 16 and over
Sponsor: NCI, Other
Protocol IDs: 1577.00, FHCRC-1577.00, MSKCC-01127, NCI-H01-0072, NCT00016068
Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CM-2008-01, 08/H0720/15, 74928896, NCT01077908
Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000441214, NCI-05-C-0203, NCI-P6330, NCT00217503
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000504022, UCSD-050126, ROCHE-VAL-108, NCT00387530
Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 04-055, MSKCC-04055, NCT00096538
Efficacy and Safety of Valcyte® as an Add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MV20145, Eudra CT: 2006-002022-29, NCT00400322
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 09038, NCI-2010-01932, NCT01199562
Start Over